Supplement Raw Phenibut Powder Phenibut

• Customization: Available
• Powder: Yes
• Customized: Negotiable
• Model NO.: QS-Phenibut
• Certification: GMP, HSE, ISO 9001, USP, BP
• Suitable for: Elderly, Children, Adult
• State: Powder
• Purity: >99%
• Product Name: Phenibut
• Name: Phenibut Powder
• Appearance: White Powder
• Colour: White
• Grade: Pharmaceutical Grade
• Assay: >99%
• Application: API
• Specific: COA
• Test Method: HPLC
• CAS: 1078-21-3
• Mf: C10h13no2
• MW: 179.219
• Density: 1.1248 (Rough Estimate)
• Melting Point: 252.5c (Rough Estimate)
• Boiling Point: 311.75 ° C (Rough Estimate)
• Transport Package: Negotiable
• Specification: >99%
• Trademark: QS-Phenibut
• Origin: Xian
• Production Capacity: 1000kg/Month

Product Description

Supplement Raw Phenibut Powder Phenibut

Product Description

Product Details

Product Name	Phenibut
Appearance	Phenibut Powder
Assay	99%
MW	179.219
MF	C10H13NO2

Phenibut is a chemical substance primarily used in the preparation of antidepressants and is an important pharmaceutical intermediate. The chemical name of Phenibut is 4-amino-3-phenylbutyric acid hydrochloride, also known as phenibut, phenibut, etc. Phenibut, as an analog of GABA (gamma aminobutyric acid), is mainly used in the preparation of antidepressants. It has sedative and anti anxiety effects and is a drug targeting the central nervous system. In addition, Phenibut can also be used in laboratory research and development processes and chemical and pharmaceutical production processes.

Application&Function

Phenibut is a synthetic central nervous system drug originally developed by Soviet scientists in the 1960s, primarily used for anti anxiety and improving cognitive function. The following are the main drug effects and related information:

1. Pharmacological mechanism of action
GABA receptor agonists:
Phenibut is a structural analogue of gamma aminobutyric acid (GABA), mainly acting on GABA-B receptors, and may also affect GABA-A receptors at high doses. By enhancing the activity of GABA (an inhibitory neurotransmitter), the excitability of the central nervous system is reduced.
Dopamine regulation:
It may indirectly increase dopamine levels and produce mild euphoria, but the mechanism is not fully understood.
2. Indications (primarily approved countries/regions)
Anxiety disorder: Short term relief of anxiety symptoms.
Insomnia: Improve sleep quality and shorten the time to fall asleep.
Post traumatic stress disorder (PTSD): Some countries use it to alleviate stress-related symptoms.
Alcohol withdrawal syndrome: Adjuvant treatment for alcohol dependence (such as in Eastern European countries like Russia and Ukraine).
3. Clinical effects
Anti anxiety: Relieve tension and excessive alertness.
Sedation/Hypnosis: Promotes deep sleep and prolongs sleep duration.
Muscle relaxation: reduces muscle tension or spasms.
Cognitive enhancement: Some users reported increased attention and emotional improvement (lack of long-term safety evidence).
4. Adverse reactions
Common: drowsiness, dizziness, headache, gastrointestinal discomfort.
Serious risk:
Dependency: Long term use (>2 weeks) can easily lead to physiological and psychological dependence.
Withdrawal symptoms: Sudden discontinuation of medication may cause anxiety, tremors, insomnia, hallucinations, and even seizures.
Respiratory depression: Increased risk when used in high doses or in combination with alcohol/opioid drugs.
5. Drug interactions
Central nervous system inhibitors (such as alcohol, , opioids): enhance sedative effects and may lead to respiratory depression.
Antidepressants/antipsychotics: may exacerbate drowsiness or extrapyramidal reactions.
Liver enzyme inducers (such as carbamazepine): accelerate Phenibut metabolism and reduce therapeutic efficacy.

 

Specification